Increasing Market Penetration
Recently Awarded Second Pharmaceutical Manufacturer Patient Support
The Company was recently awarded its second major program with a
globally-recognized, industry-leading pharmaceutical manufacturer. The
details of the contract are expected to be finalized by June 30, 2008
with an anticipated initial launch of the program in the second half of
calendar year 2008.
The Patient Support Program is expected to include the direct
fulfillment of the Sharps Disposal By Mail System(R) to the
pharmaceutical manufacturers' patients, who will use the product to
provide a convenient means of disposal for their self-injecting
patients. Sharp's proprietary SharpsTracer(TM) system is used to track
the return of the Sharps Disposal By Mail System(R) by the patient to
the treatment facility, where the package is scanned and weighed prior
to destruction. This data, managed in Sharps' proprietary
SharpsTracer(TM) system, is electronically transmitted to the
pharmaceutical manufacturer which assists them in monitoring drug usage
and provides a touch point for individual patient follow-up.
The Company believes its successful experience fulfilling products and
services for its first contract with a top ten pharmaceutical
manufacturer, as well as its fully-integrated capabilities, were
differentiating factors leading to the award of this second program.
Additional Pharmaceutical Manufacturer Opportunities
In addition to the award of the second Patient Support Program, the
Company is in discussion
|SOURCE Sharps Compliance Corp.|
Copyright©2008 PR Newswire.
All rights reserved